Solving molecular puzzles
Professor Balasubramanian and his team are experts in how molecules fit together and work inside cells. By combining this knowledge with sophisticated lab techniques, they are developing drugs that can switch off certain genes that cause cancer, slowing the growth of cancer cells.
These drugs could be an effective way to target tumours while avoiding damage to healthy cells, helping to reduce side effects. The team also hope that it will be more difficult for the cancer cells to develop resistance to these highly targeted drugs.
Professor Balasubramanian is working with doctors to test these potential new drugs, bringing us closer to the next generation of cancer treatments.
Other research projects by Shankar Balasubramanian
Funding period: 01 October 2010 to 30 September 2015
Funding period: 01 October 2006 to 30 September 2014
Funding period: 01 April 2010 to 31 March 2015
Distinct functions of maternal and somatic Pat1 protein paralogs
Small-molecule-mediated G-quadruplex isolation from human cells
Nat Chem.2011;2 :1095-1098